Data / Federal awards / NAICS 541380 / LOVELACE BIOMEDICAL RESEARCH INSTITUTE
LOVELACE BIOMEDICAL RESEARCH INSTITUTE: 59 federal contract awards, $21.9 million obligated (FY2024 to FY2027)
Updated October 6, 2026. Source: USAspending.gov.
LOVELACE BIOMEDICAL RESEARCH INSTITUTE (UEI MBT9RXJJ7428), Albuquerque, NM, received 59 federal prime contract awards with $21.9 million obligated in fiscal years 2024 to 2027, from 2 agencies under 7 NAICS codes. Its largest buyer is Department of Health and Human Services ($21.6 million) and its largest code is NAICS 541380 Testing Laboratories and Services.
The request: Every federal contract awarded under NAICS 541380, with the winner, the agency and the value. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every federal contract award on USAspending.gov and every open opportunity on SAM.gov, and this page is that reading. Ask for the awards in your niche and the winners, agencies, values and recompetes arrive in your sheet, CRM, Slack or agent as they are reported.
- UEI
- MBT9RXJJ7428
- Location
- Albuquerque, NM
- Business size
- Other Than Small Business
- Contract awards
- 59
- Obligated
- $21.9 million
- First action in window
- 2023-10-03
- Latest action
- 2026-09-25
Where the work is
NAICS codes, with the other winners in each.
| NAICS | Industry | Awards | Obligated |
|---|---|---|---|
| 541380 | Testing Laboratories and Services | 3 | $9.6 million |
| 541714 | Research and Development in Biotechnology (except Nanobiotechnology) | 19 | $6.7 million |
| 541690 | Other Scientific and Technical Consulting Services | 5 | $3 million |
| 541712 | Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) | 4 | $2.8 million |
| 541715 | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | 24 | $946,213 |
| 511210 | Software Publishers | 2 | $311,075 |
| 541711 | Research and Development in Biotechnology | 2 | $-1,363,328 |
Buying agencies
| Agency | Awards | Obligated |
|---|---|---|
| Department of Health and Human Services | 56 | $21.6 million |
| Department of Defense | 3 | $311,075 |
Obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2024 | $948,075 |
| FY2025 | $18.9 million |
| FY2026 | $2.1 million |
Contract awards
The 50 largest of 59 awards by dollars obligated in fiscal years 2024 to 2027.
| Award ID | Agency | Type | NAICS | What it buys | Obligated in window | Award value | Starts | Ends | Place of performance | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| 75F40125P00216 | Department of Health and Human Services | Purchase Order | 541380 | SOLE SOURCE AWARD OF A 24-MONTH PERIOD, FIRM FIXED PRICE (FFP), ENDS TOXICOLOGICAL STUDIES FOR CENTER FOR TOBACCO PRODUCTS (CTP). | $7,058,882 | $7,058,882 | September 19, 2025 | September 29, 2027 | Albuquerque, NM | usaspending.gov |
| 75A50123F61001 | Department of Health and Human Services | Delivery Order | 541714 | RADNUC 2201: PERFORMANCE VERIFICATION OF INSTITUTIONAL RADIATION DOSE RESPONSE FOR ACUTE RADIATION SYNDROME (ARS) ANIMAL MODELS (RODENT, RAB | $3,918,627 | $5,905,018 | September 29, 2023 | April 17, 2027 | Albuquerque, NM | usaspending.gov |
| 75A50126F61002 | Department of Health and Human Services | Delivery Order | 541714 | RTOR BIO-AMT-2312: ASSESSMENT OF THE THERAPEUTIC POTENTIAL OF CHLOROQUINE AND OSELTAMIVIR IN TWO (2) LETHAL MODELS OF INFLUENZA A H5N1 | $3,723,027 | $3,723,027 | August 26, 2026 | April 25, 2028 | Albuquerque, NM | usaspending.gov |
| 75N95020F00001 | Department of Health and Human Services | Delivery Order | 541712 | NON-CLINICAL SAFETY ASSESSMENT OF GENE THERAPY (PCCA, MMAB, DOK7 AND COLQ) TO SUPPORT PLATFORM GENE THERAPY FOR CONGENITAL MYASTHENIC DISEAS | $3,028,505 | $5,298,497 | September 25, 2020 | May 31, 2027 | Albuquerque, NM | usaspending.gov |
| 75F40126F19003 | Department of Health and Human Services | Delivery Order | 541690 | NICOTINE FLUX: INVESTIGATING THE IMPACT OF ENDS OUTPUT POWER AND HEATING ELEMENT ON ABUSE LIABILITY | $3,017,553 | $3,017,553 | September 14, 2026 | September 13, 2030 | Beltsville, MD | usaspending.gov |
| 75F40119C10161 | Department of Health and Human Services | Definitive Contract | 541380 | STUDY OF E-CIGARETTE AEROSOL TOXICITY IN IN VIVO NONCLINICAL MODELS. | $2,526,628 | $38,812,829 | September 26, 2019 | June 30, 2025 | Silver Spring, MD | usaspending.gov |
| 75N95021F00001 | Department of Health and Human Services | Delivery Order | 541715 | CHARACTERIZATION OF A NON-PARALYZING BONT-BASED BIOPHARMACEUTICAL FOR THE TREATMENT OF NEUROPATHIC PAIN | $350,840 | $1,633,884 | September 24, 2021 | June 30, 2027 | Albuquerque, NM | usaspending.gov |
| 75N98026F00001 | Department of Health and Human Services | Delivery Order | 541714 | GLP REPEAT DOSE TOXICOLOGY STUDY FOR A LIVE-ATTENUATED RESPIRATORY VIRUS VACCINE. | $339,534 | $339,534 | September 28, 2026 | March 27, 2027 | Rockville, MD | usaspending.gov |
| W81XWH22P0157 | Department of Defense | Purchase Order | 511210 | LICENSE AND MAINTENANCE SUPPORT, ON-SITE SUPPORT SERVICES FOR VSP WRAIR. | $311,075 | $741,851 | September 16, 2022 | September 19, 2027 | Silver Spring, MD | usaspending.gov |
| 75N95023F00002 | Department of Health and Human Services | Delivery Order | 541715 | EFFICACY AND SAFETY EVALUATION OF LEAD GENE THERAPY CANDIDATE IN NEUROMUSCULAR JUNCTION (NMJ) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY M | $303,277 | $1,899,147 | September 29, 2023 | June 30, 2028 | Albuquerque, NM | usaspending.gov |
| 75N95024F00002 | Department of Health and Human Services | Delivery Order | 541715 | RESPIRATORY INTERACTION STUDIES IN RODENTS, ABILITY OF A TEST ARTICLE TO REVERSE THE RESPIRATORY DEPRESSANT EFFECTS OF OPIOIDS. TO5. PERIOD | $211,128 | $211,128 | March 21, 2024 | April 23, 2025 | Albuquerque, NM | usaspending.gov |
| 75N93022F00001 | Department of Health and Human Services | Delivery Order | 541715 | THE CONTRACTOR SHALL PERFORM THE TRANSFER, VALIDATION AND QUALIFICATION OF BIOANALYTICAL METHODS FOR DETECTION OF CABOTEGRAVIR AND LEVONORGE | $193,918 | $680,219 | November 15, 2021 | April 15, 2026 | Albuquerque, NM | usaspending.gov |
| 75N95023F00001 | Department of Health and Human Services | Delivery Order | 541715 | CHARACTERIZATION OF SPONTANEOUS OSTEOGENESIS AFTER SURGICAL SEGMENTAL BONE DEFECT IN A LARGE ANIMAL | $192,050 | $385,704 | August 7, 2023 | November 7, 2024 | Albuquerque, NM | usaspending.gov |
| 75N95024F00001 | Department of Health and Human Services | Delivery Order | 541715 | EVALUATION OF POTENTIAL RESPIRATORY STIMULANT. TO4. PERIOD OF PERFORMANCE: MARCH 21, 2024 - MARCH 20, 2025. | $140,848 | $140,848 | March 21, 2024 | April 28, 2025 | Albuquerque, NM | usaspending.gov |
| 75N95020F00002 | Department of Health and Human Services | Delivery Order | 541715 | CHARACTERIZATION OF A NON-ADDICTIVE SMALL MOLECULE THERAPEUTICS FOR THE MANAGEMENT OF NON-CANCER PAIN PERIOD OF PERFORMANCE SEPTEMBER 18, 20 | $120,890 | $2,327,263 | September 18, 2020 | April 28, 2025 | Albuquerque, NM | usaspending.gov |
| 75A50123F61001 | Department of Health and Human Services | Delivery Order | 541714 | BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIES | $79,841 | $100,283 | July 20, 2023 | July 19, 2027 | Albuquerque, NM | usaspending.gov |
| 75N95020F00004 | Department of Health and Human Services | Delivery Order | 541715 | CHARACTERIZATION OF A DOWNSTREAM GENE THERAPEUTIC FOR THE REPARATIVE TREATMENT OF SEVERE FRACTURES PERIOD OF PERFORMANCE SEPTEMBER 24, 2020 | $53,553 | $1,317,349 | September 22, 2020 | December 31, 2024 | Albuquerque, NM | usaspending.gov |
| 75N95020F00005 | Department of Health and Human Services | Delivery Order | 541715 | EFFICACY AND SAFETY EVALUATION OF A LEAD GENE THERAPY CANDIDATE IN PROPIONIC ACIDEMIA (PA) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METH | $51,059 | $2,274,579 | September 25, 2020 | July 15, 2025 | Albuquerque, NM | usaspending.gov |
| 75N95022F00001 | Department of Health and Human Services | Delivery Order | 541715 | BIOANALYTICAL SUPPORTS FOR A GLP TOX/BIODISTRIBUTION STUDY IN MINI-PIGS | $44,201 | $792,052 | June 17, 2022 | June 30, 2025 | Albuquerque, NM | usaspending.gov |
| 75N92024P00303 | Department of Health and Human Services | Purchase Order | 541380 | 24-015894 NHLBI POPULATION SCIENCES BRANCH REQUIRES PULMONARY FUNCTION TESTING TO DETERMINE IF THE FLEXIVENT METHOD OF PULMONARY FUNCTION TE | $16,653 | $16,653 | September 10, 2024 | November 15, 2024 | Albuquerque, NM | usaspending.gov |
| 75N93025D00021 | Department of Health and Human Services | IDC | 541715 | EVALUATION AND TESTING SERVICES (ETS) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES. | $10,000 | $136,588,701 | September 30, 2025 | usaspending.gov | ||
| 75N92024F00001 | Department of Health and Human Services | Delivery Order | 541714 | GENE THERAPY RESOURCE PROGRAM (GTRP): PHARMACOLOGY AND TOXICOLOGY CORE LABORATORY - TASK AREA A: CORE ADMINISTRATIVE ACTIVITIES | $3,553 | $3,553 | December 19, 2023 | June 30, 2024 | Albuquerque, NM | usaspending.gov |
| 75N95024F00001 | Department of Health and Human Services | Delivery Order | 541714 | KICK-OFF MEETING FOR THE PHARMACOLOGY STUDIES AND ANIMAL MODEL DEVELOPMENT AND RELATED SERVICES FOR DRUG DEVELOPMENT IDIQ CONTRACT. | $1,000 | $1,000 | August 6, 2024 | September 30, 2024 | Albuquerque, NM | usaspending.gov |
| 75A50122F61001 | Department of Health and Human Services | Delivery Order | 541711 | SUPPORT NON-CLINICAL IMMUNOGENICITY STUDIES OF SARS-COV-2 MICRONEEDLE PATCH VACCINES CANDIDATES IN A SMALL-ANIMAL MODEL | $0 | $756,111 | March 8, 2022 | December 7, 2023 | Albuquerque, NM | usaspending.gov |
| 75F40122F19001 | Department of Health and Human Services | Delivery Order | 541690 | CTP-2022-111127 - SALTS | $0 | $2,130,022 | September 22, 2022 | February 22, 2027 | Silver Spring, MD | usaspending.gov |
| 75F40123F19001 | Department of Health and Human Services | Delivery Order | 541690 | TASK ORDER 1 -TITLE: ARE REDUCTIONS IN BOE, BOPH, AND OTHER HEALTH RISK MARKERS PROPORTIONAL TO REDUCTIONS IN CIGARETTE SMOKING UPON SWITCHI | $0 | $3,872,713 | September 27, 2023 | April 18, 2025 | Beltsville, MD | usaspending.gov |
| 75F40123F19002 | Department of Health and Human Services | Delivery Order | 541690 | TASK ORDER 2 - EXAMINING THE INFLUENCE OF SYNTHETIC COOLING AGENTS ON CIGARETTE SENSORY AND SUBJECTIVE EFFECTS AND USE BEHAVIOR | $0 | $1,251,731 | September 29, 2023 | September 29, 2027 | Beltsville, MD | usaspending.gov |
| 75A50122D00008 | Department of Health and Human Services | IDC | 541714 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE(CHEM) - IDIQ FOR BARDA CRN ANIMAL MODEL DEVELOPMENT | $0 | $45,000,000 | July 28, 2022 | usaspending.gov | ||
| 75A50122D00013 | Department of Health and Human Services | IDC | 541714 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE (RADNUC) - IDIQ FOR BARDA CRN ANIMAL MODEL DEVELOPMENT | $0 | $100,000,000 | September 9, 2022 | usaspending.gov | ||
| 75N93021D00031 | Department of Health and Human Services | IDC | 541714 | COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMS | $0 | $545,452,906 | September 1, 2021 | usaspending.gov | ||
| 75N95020F00003 | Department of Health and Human Services | Delivery Order | 541715 | NATURAL HISTORY STUDIES IN NEUROMUSCULAR JUNCTION (NMJ) DISEASE MOUSE MODELS. PERIOD OF PERFORMANCE SEPTEMBER 28, 2020 - DECEMBER 31, 2021 | $0 | $2,011,717 | September 28, 2020 | July 31, 2025 | Albuquerque, NM | usaspending.gov |
| 75N95024D00021 | Department of Health and Human Services | IDC | 541715 | SAFETY EVALUATION AND TOXICOLOGY STUDIES AND RELATED SERVICES FOR DRUG DEVELOPMENT | $0 | $48,622,546 | June 20, 2024 | usaspending.gov | ||
| 75N95022F00001 | Department of Health and Human Services | Delivery Order | 541715 | ASSESSMENT OF POTENTIAL TREATMENTS FOR DRUG-INDUCED RESPIRATORY DEPRESSION AND OVERDOSE TOXICITY. POP: SEPTEMBER 26, 2022 - MARCH 25, 2023. | $0 | $148,800 | September 26, 2022 | September 30, 2024 | Albuquerque, NM | usaspending.gov |
| 75N95022F00002 | Department of Health and Human Services | Delivery Order | 541715 | ASSESSMENT OF POTENTIAL TREATMENTS FOR DRUG-INDUCED RESPIRATORY DEPRESSION AND OVERDOSE TOXICITY. POP: SEPTEMBER 26, 2022 - MARCH 25, 2023. | $0 | $162,965 | September 26, 2022 | September 30, 2024 | Albuquerque, NM | usaspending.gov |
| HT001122D0030 | Department of Defense | IDC | 541714 | OMNIBUS IV MILITARY MEDICAL RESEARCH AND DEVELOPMENT | $0 | $10,000,000,000 | June 20, 2022 | usaspending.gov | ||
| 75A50122D00021 | Department of Health and Human Services | IDC | 541714 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE - BASE (BIO) - IDIQ FOR BARDA BIOLOGICAL ANIMAL MODEL AND MCM DEVELOPMENT | $0 | $100,000,000 | September 30, 2022 | usaspending.gov | ||
| 75F40123D00039 | Department of Health and Human Services | IDC | 541690 | AWARD OF FIVE-YEAR IDIQ FOR CTP- ASSESSING TOBACCO-RELATED CLINICAL OUTCOMES AND HUMAN BEHAVIORS IN TOBACCO | $0 | $25,000,000 | September 26, 2023 | usaspending.gov | ||
| 75N93022D00009 | Department of Health and Human Services | IDC | 541715 | EO14042 - THE CONTRACTOR SHALL PROVIDE PRECLINICAL DEVELOPMENT SUPPORT FOR CANDIDATE PRODUCTS AND DRUG DEVELOPMENT ACTIVITIES. | $0 | $107,274,471 | November 15, 2021 | usaspending.gov | ||
| 75N93023D00004 | Department of Health and Human Services | IDC | 541715 | RESOURCES TO ADVANCE PEDIATRICS AND HIV PREVENTION SCIENCE | $0 | $98,878,757 | April 15, 2023 | usaspending.gov | ||
| HHSF223201510001I | Department of Health and Human Services | IDC | 541712 | IGF::OT::IGF, IN VITRO TOXICOLOGY OF TOBACCO AND RELATED PRODUCTS | $0 | $0 | June 30, 2015 | usaspending.gov | ||
| 75N95024D00027 | Department of Health and Human Services | IDC | 541714 | PHARMACOLOGY STUDIES AND ANIMAL MODEL DEVELOPMENT AND RELATED SERVICES FOR DRUG DEVELOPMENT | $0 | $48,882,666 | August 6, 2024 | usaspending.gov | ||
| 75N92019D00017 | Department of Health and Human Services | IDC | 541714 | THE NHLBI REQUIRES THE GENE THERAPY RESOURCE PROGRAM (GTRP) SUPPORT TRANSLATIONAL GENE THERAPY RESEARCH BY PROVIDING RESOURCES AND SERVICES | $0 | $13,300,000 | December 19, 2018 | usaspending.gov | ||
| 75N95022D00019 | Department of Health and Human Services | IDC | 541715 | ASSESSMENT OF POTENTIAL TREATMENTS FOR DRUG-INDUCED RESPIRATORY DEPRESSION AND OVERDOSE TOXICITY. ORDERING PERIOD: SEPTEMBER 26, 2022 - SEPT | $0 | $6,500,000 | September 26, 2022 | usaspending.gov | ||
| 75N95019D00030 | Department of Health and Human Services | IDC | 541715 | CRO SUPPORT FOR NCATS MEDICINAL CHEMISTRY FOR LEAD OPTIMIZATION. | $0 | $17,891,012 | September 26, 2019 | usaspending.gov | ||
| W81XWH17C0235 | Department of Defense | Definitive Contract | 511210 | IGF::OT::IGF ANIMAL MANAGEMENT SYSTEM SOFTWARE LICENSE/SUPPORT | $-0 | $978,700 | September 1, 2017 | August 31, 2022 | Silver Spring, MD | usaspending.gov |
| 75N93021F00001 | Department of Health and Human Services | Delivery Order | 541714 | COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMS | $-2,000 | $0 | September 1, 2021 | August 31, 2022 | Bethesda, MD | usaspending.gov |
| 75N92021F00001 | Department of Health and Human Services | Delivery Order | 541714 | GENE THERAPY RESOURCE PROGRAM (GTRP): PHARMACOLOGY/TOXICOLOGY CORE LABORATORY - SCIENTIFIC PROJECT FOR RSA NO. 2057 (RADER) | $-28,989 | $1,609,194 | September 8, 2021 | June 30, 2024 | Albuquerque, NM | usaspending.gov |
| 75N92023F00001 | Department of Health and Human Services | Delivery Order | 541714 | GENE THERAPY RESOURCE PROGRAM (GTRP): PHARMACOLOGY AND TOXICOLOGY CORE LABORATORY | $-62,736 | $171,742 | September 25, 2023 | June 30, 2024 | Albuquerque, NM | usaspending.gov |
| 75N95019F00090 | Department of Health and Human Services | Delivery Order | 541715 | EVALUATION OF DRUG EFFICACY IN A RAT MODEL OF NEUROPATHIC PAIN | $-63,192 | $292,814 | September 24, 2019 | September 24, 2020 | Albuquerque, NM | usaspending.gov |
| 75N93019F00131 | Department of Health and Human Services | Delivery Order | 541712 | TRANSFER AND VALIDATION OF BIOANALYTICAL METHOD FOR DETECTION OF CABOTEGRAVIR IN RAT PLASMA | $-93,712 | $255,825 | August 1, 2019 | July 31, 2022 | Albuquerque, NM | usaspending.gov |
Also on SpecStream
- All recipients under NAICS 541380 Testing Laboratories and Services
- All recipients under NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- All recipients under NAICS 541690 Other Scientific and Technical Consulting Services
- Open opportunities under NAICS 541380
- Open opportunities under NAICS 541714
- Open opportunities under NAICS 541690
Public U.S. federal spending data (U.S. Department of the Treasury). Obligations are the contract actions dated in fiscal years 2024 to 2027 of the USAspending.gov award archive of 2026-10-06; a contract's total value is its current value as USAspending reports it, including earlier years. Recipients are matched on their SAM.gov UEI, never on the name, and are shown as the government prints them. Sole proprietorships and opted-out entities count in the totals and are not named. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.